All Studies Meta Analysis

Ivermectina en agentes de salud e IVERCOR COVID19

IVERCOR PREP, Preliminary Results

Dec 2020

Post
Facebook

Source PDF All Studies Meta AnalysisMeta

Download Image

Ivermectin for COVID-19

4th treatment shown to reduce risk in August 2020, now with p < 0.00000000001 from 105 studies, recognized in 23 countries.

Lower risk for mortality, ventilation, ICU admission, hospitalization, recovery, cases, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

5,100+ studies for 109 treatments. c19ivm.org

Report on ivermectin prophylaxis in a hospital in Argentina showing lower cases for healthcare workers taking ivermectin.

Results have been published in the press1 (interim results), and a presentation posted online:2, however there is no formal publication to date.

These results would be expected to receive priority publication due to the predicted impact on the pandemic and confirmation of previous prophylaxis studies. The lack of formal publication suggests a negative publication bias that may be due to politicization in the authors' location.

Note that this prophylaxis study is different to the Vallejos early treatment trial.

This is the 28th of 105 COVID-19 controlled studies for ivermectin, which collectively show efficacy with p<0.0000000001 (1 in 774 quintillion).

52 studies are RCTs, which show efficacy with p=0.00000021.

This study is excluded in the after exclusion results of meta analysis: minimal details provided.

Important missing comments or errors? Let us know.

risk of case, 73.4% lower, RR 0.27, p < 0.001, treatment 13 of 389 (3.3%), control 61 of 486 (12.6%), NNT 11.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

1. lanacion.com.ar, www.lanacion.com.ar/sociedad/coronavirus-argentina-advertencias-evidencias-consumo-ivermectina-covid-19-nid2528989/.www.lanacion.com.ar/sociedad/coronavirus-argentina-advertencias-evidencias-consumo-ivermectina-covid-19-nid2528989/.

2. web.archive.org, web.archive.org/web/20210226215453/https://twitter.com/Covid19Crusher/status/1365420061859717124.web.archive.org/web/20210226215453/https://twitter.com/Covid19Crusher/status/1365420061859717124.

IVERCOR PREP et al., 20 Dec 2020, retrospective, Argentina, preprint, 1 author, dosage 12mg weekly.

This Paper Ivermectin All

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0